Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression
Zhenzhen Pan, K. Wang, Xiniao Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 142
Precision Medicine: Disease Subtyping and Tailored Treatment
Richard Wang, Zhixiang Wang
Cancers (2023) Vol. 15, Iss. 15, pp. 3837-3837
Open Access | Times Cited: 121
Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer
Wenjun Mao, Yun Cai, Danrong Chen, et al.
JCI Insight (2022) Vol. 7, Iss. 18
Open Access | Times Cited: 91
Dysregulated Signalling Pathways Driving Anticancer Drug Resistance
Nauf Bou Antoun, Athina‐Myrto Chioni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12222-12222
Open Access | Times Cited: 45
The Role of Oxidative Stress in Tumorigenesis and Progression
Kexin Li, Zhangyuzi Deng, Chunran Lei, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 441-441
Open Access | Times Cited: 20
Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy
Shutong Li, Aoxue Wang, Yongya Wu, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 300-334
Closed Access | Times Cited: 26
Association between abnormal lipid metabolism and tumor
Chunyu Li, Fei Wang, Lili Cui, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 23
Targeting lipid metabolism of macrophages: A new strategy for tumor therapy
Nan Shao, Hui Qiu, Jing Liu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 15
LncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through ALDH2
Xiang Nie, Jiahui Fan, Dai B, et al.
Circulation Research (2024) Vol. 134, Iss. 4, pp. 425-441
Open Access | Times Cited: 13
Sulfotransferase SULT2B1 facilitates colon cancer metastasis by promoting SCD1‐mediated lipid metabolism
Gang Che, Wankun Wang, Jiawei Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 11
Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities
Wen G. Jiang, Weilin Jin, Aman Xu
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2044-2071
Open Access | Times Cited: 8
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition
Fangquan Chen, Junhao Lin, Rui Kang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 8, pp. 1515-1527
Closed Access | Times Cited: 8
Inhibition of the Sp1/PI3K/AKT signaling pathway exacerbates doxorubicin-induced cardiomyopathy
Guojian Xiang, Tingting Shi, Cornelius Obinna Nwaele, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025), pp. 119960-119960
Closed Access | Times Cited: 1
Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations
Qiangqiang He, Meiyu Qu, Hangyang Bao, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 70, pp. 41-53
Closed Access | Times Cited: 19
Cholesterol Metabolism in Cancer and Cell Death
Fangquan Chen, Yanjiao Lu, Junhao Lin, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 1-3, pp. 102-140
Closed Access | Times Cited: 19
The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy
Hongtu Hu, Weiwei Li, Yiqun Hao, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101690-101690
Open Access | Times Cited: 6
Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R/PKA/SP1/ERp29/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization
Ya Hui, Zhiqiang Xu, Jiaxiu Li, et al.
Metabolism (2022) Vol. 138, pp. 155340-155340
Closed Access | Times Cited: 23
Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
Wenzhe Yi, Dan Yan, Dangge Wang, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 4, pp. 248-267
Open Access | Times Cited: 14
Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non–small-cell lung cancer
Li Liu, Shuo Zhang, Haiyan Yang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
m6A-Mediated Induction of 7-Dehydrocholesterol Reductase Stimulates Cholesterol Synthesis and cAMP Signaling to Promote Bladder Cancer Metastasis
Youmiao Zeng, Yongbo Luo, Keyuan Zhao, et al.
Cancer Research (2024) Vol. 84, Iss. 20, pp. 3402-3418
Closed Access | Times Cited: 5
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation
Tao Zhang, Zilu Pan, Jing Gao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression
Philipp Hartmann, Denis I. Trufa, Katja Hohenberger, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3‐Dependent Manner
Zhehui Zhu, Yuegui Guo, Yun Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 12
Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB
Qi Liu, Yajuan Zhang, Huimin Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
YY2-CYP51A1 signaling suppresses hepatocellular carcinoma progression by restraining de novo cholesterol biosynthesis
Lingxian Wang, Wei Duan, Cao Ruan, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167658-167658
Closed Access
Page 1 - Next Page

Scroll to top